Observational data during the COVID-19 pandemic: opportunity with uncertainty

Heart. 2020 Oct;106(19):1461-1462. doi: 10.1136/heartjnl-2020-317486. Epub 2020 Aug 5.

Authors

Sam Straw¹, Klaus K Witte²

Affiliations

¹ Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK.
² Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK k.k.witte@leeds.ac.uk.

PMID: 32759292
DOI: 10.1136/heartjnl-2020-317486

No abstract available

Keywords: cardiac risk factors and prevention; epidemiology.

Publication types

Editorial
Comment

MeSH terms

Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors*
Betacoronavirus
COVID-19
Cohort Studies
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Uncertainty

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors